St. Jude is identifying the long-term effects of cancer therapy; finding better ways to predict health risks; and helping survivors live longer, healthier lives
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.
Working closely together, St. Jude scientists and clinicians translate laboratory breakthroughs into novel treatment options for pediatric patients.
St. Jude is developing innovative gene therapy approaches for patients with blood diseases, immune disorders and other inherited diseases.
Children with "bubble boy" disease are highly susceptible to severe, fatal infections. Learn about a St. Jude study that demonstrates how gene therapy cures SCID.
A cancer originates in a child's DNA. Learn how St. Jude is using new technologies to reveal these genetic beginnings and develop cures.
Transcription therapy studies the causes of abnormal gene expression in pediatric leukemias, gliomas, brain cancers, and neurological and immune disorders
Learn how investigators at St. Jude are transforming the way we understand and treat sickle cell disease and other ß-hemoglobinopathies.
With the first proton therapy center in the world dedicated solely to children, St. Jude combines personalized care with one of the most advanced forms of radiation therapy available to patients.
Spatial transcriptomics are a collection of -omics technologies aimed at visualizing RNA expression profiles within in-tact tissues. Learn more here.